Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	15	13	21	28	8	6	Upgrade
Market Cap Growth	-27.56%	-36.66%	-25.30%	235.94%	31.80%	9.57%	Upgrade
Enterprise Value	1	-0	6	26	7	6	Upgrade
Last Close Price	0.02	0.02	0.03	0.05	0.04	0.04	Upgrade
PS Ratio	15.59	16.98	36.12	672.87	1383.02	3887.70	Upgrade
PB Ratio	0.41	0.38	0.62	0.93	0.91	0.80	Upgrade
P/TBV Ratio	0.42	0.39	0.65	0.93	0.90	0.80	Upgrade
P/OCF Ratio	-	-	-	-	-	34.03	Upgrade
EV/Sales Ratio	0.99	-	9.74	627.14	1113.85	3744.79	Upgrade
Asset Turnover	0.03	0.02	0.02	0.00	0.00	0	Upgrade
Quick Ratio	12.84	13.77	113.19	76.19	16.66	2.75	Upgrade
Current Ratio	12.90	13.77	113.22	83.72	16.71	2.79	Upgrade
Return on Equity (ROE)	-1.92%	-1.54%	-2.51%	-11.12%	-5.47%	-17.89%	Upgrade
Return on Assets (ROA)	-0.98%	-0.79%	-1.49%	-6.45%	-5.59%	-15.02%	Upgrade
Return on Capital (ROIC)	-1.01%	-0.80%	-1.50%	-6.51%	-5.71%	-15.61%	Upgrade
Earnings Yield	-4.58%	-4.00%	-3.81%	-7.80%	-5.59%	-23.63%	Upgrade
FCF Yield	-23.04%	-13.85%	-9.21%	-6.62%	-14.50%	-6.21%	Upgrade
Buyback Yield / Dilution	16.73%	-8.35%	-101.97%	-51.18%	-26.98%	-27.14%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.